Laboratory Corp of America Holdings Stock News

LabCorp (LH) delivered earnings and revenue surprises of -0.64% and 5.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Shares of Labcorp LH, +0.76% tumbled 4.7% in premarket trading on Thursday after the diagnostics company said revenue in the third quarter of 2022 came in lower than expected as fewer people got PCR o

U.S. market indexes rose on Thursday morning as investors were encouraged by several key earnings reports and Treasury yields continued to climb.

Labcorp CEO Adam Schechter speaks about various aspects of the heath care industry at Yahoo Finance's All Markets Summit.

Quest Diagnostics in its latest media report notes that demand for COVID-19 molecular diagnostic testing declined in August compared to the prior month.

Gold futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the third quarter of 2022 before the market opens on Thursday, Oct

Wall Street analysts follow S&P 500 stocks more closely than almost anyone. But even they get it wrong sometimes, too.

LabCorp announced that it is pursuing a tax-free spinoff of its Drug Development segment. The transaction will separate a slower-growing, highly profitable cash cow from a high growth business, allowi

Within the last quarter, Laboratory Corp (NYSE:LH) has observed the following analyst ratings:   Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0 0 0 Last 30

BD's (BDX) tie-up with Accelerate Diagnostics is expected to strengthen the fight to combat the global threat of antimicrobial resistance, thereby boosting patient care.

Labcorp is a well-run company that should benefit from long-term secular trends in the healthcare industry. It benefits from its large patient database, which aids its drug development services busine

BD's (BDX) latest partnership is expected to provide life-changing treatments for cancer and other diseases, thereby improving patient care.

Professional money managers have a strong preference for one stock sector in particular, along with cash dividends.

The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet.